Your browser doesn't support javascript.
loading
Cardiovascular risk-enhancing factors and coronary artery calcium in South Asian American adults: The MASALA study.
Shah, Harini; Garacci, Emma; Behuria, Supreeti; Cainzos-Achirica, Miguel; Kandula, Namratha R; Kanaya, Alka M; Shah, Nilay S.
Afiliación
  • Shah H; Medical College of Wisconsin, Milwaukee, WI, USA.
  • Garacci E; Medical College of Wisconsin, Milwaukee, WI, USA.
  • Behuria S; Medical College of Wisconsin, Milwaukee, WI, USA.
  • Cainzos-Achirica M; Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA.
  • Kandula NR; Division of General Internal Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Kanaya AM; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Shah NS; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Am J Prev Cardiol ; 13: 100453, 2023 Mar.
Article en En | MEDLINE | ID: mdl-36636125
Objectives: The 2018 and 2019 U.S. guidelines for the management of cholesterol and primary prevention of atherosclerotic cardiovascular disease (ASCVD) recommend consideration of cardiovascular risk-enhancing factors (REFs), including South Asian ancestry, to refine ASCVD risk estimation. However, the associations of REFs with atherosclerosis are unclear in South Asian American adults, who have a disproportionately elevated premature coronary heart disease risk. In the Mediators of Atherosclerosis in South Asians Living in America (MASALA) cohort, we investigated associations of individual REFs, or the number of REFs, with coronary artery calcium (CAC). Methods: Using baseline and follow-up data from MASALA, we evaluated the association of REFs (family history of ASCVD, low-density lipoprotein cholesterol ≥160 mg/dL, triglycerides ≥175 mg/dL, lipoprotein(a) >50 mg/dL, high-sensitivity C-reactive protein [hsCRP] ≥2.0 mg/dL, ankle-brachial index <0.9, chronic kidney disease, metabolic syndrome), individually and combined, with baseline prevalent CAC, any CAC progression (including incident CAC and CAC progression), and annual CAC progression rates using multivariable logistic regression and generalized linear models. Results: Among 866 adults, mean age was 55 [SD 9] years and 47% were female. There were no significant associations of REFs with baseline prevalent CAC or any CAC progression (incident CAC and CAC progression at Exam 2) after adjustment. Among the 56% of participants who had any CAC progression, having 3+ REFs was associated with a significantly higher annual CAC progression rate (adjusted rate ratio [aRR] 1.94, 95% CI 1.39-2.72) vs. having 0 REFs. The annual CAC progression rate was 20% higher per additional REF (aRR 1.20, 95% CI 1.09-1.32). Findings were similar after excluding statin users, and among those with low 10-year ASCVD risk (<5%). Conclusions: Among South Asian American adults, we found no association of REFs with prevalent CAC at baseline or having any CAC progression. Among those with any CAC progression, a higher number of REFs was associated with higher annual CAC progression rates.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Prev Cardiol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Prev Cardiol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos